Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (531-540 of 1,058) with videos related to

Pageof 106
Sort By:
British Journal of Haematology|August 23, 2014
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patientsJohn M Pagel, Stephen E Spurgeon, John C Byrd, et al.
Blood|October 17, 2015
Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemiaJohn C Byrd, Joseph M Flynn, Thomas J Kipps, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanismJ F Urban, L Schopf, S C Morris, et al.
Pediatric Obesity|March 22, 2012
Effects of a randomized maintenance intervention on adiposity and metabolic risk factors in overweight minority adolescentsJ N Davis, E E Ventura, A Tung, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Journal of the American Chemical Society|July 31, 2019
Impact of Stereo- and Regiochemistry on Energetic MaterialsLisa M Barton, Jacob T Edwards, Eric C Johnson, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 24, 2013
A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted deliveryYicheng Mao, Jiang Wang, Yuan Zhao, et al.
Biomaterials|June 4, 2013
Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cellsBo Yu, Yicheng Mao, Yuan Yuan, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
The Journal of Biological Chemistry|March 15, 1993
Human gastric mucin. Identification of a unique species by expression cloningN W Toribara, A M Roberton, S B Ho, et al.
Pageof 106

Showing results (531-540 of 1,058) with videos related to

Sort By:
Pageof 106
British Journal of Haematology|August 23, 2014
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patientsJohn M Pagel, Stephen E Spurgeon, John C Byrd, et al.
Blood|October 17, 2015
Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemiaJohn C Byrd, Joseph M Flynn, Thomas J Kipps, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2000
Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanismJ F Urban, L Schopf, S C Morris, et al.
Pediatric Obesity|March 22, 2012
Effects of a randomized maintenance intervention on adiposity and metabolic risk factors in overweight minority adolescentsJ N Davis, E E Ventura, A Tung, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Journal of the American Chemical Society|July 31, 2019
Impact of Stereo- and Regiochemistry on Energetic MaterialsLisa M Barton, Jacob T Edwards, Eric C Johnson, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 24, 2013
A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted deliveryYicheng Mao, Jiang Wang, Yuan Zhao, et al.
Biomaterials|June 4, 2013
Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cellsBo Yu, Yicheng Mao, Yuan Yuan, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
The Journal of Biological Chemistry|March 15, 1993
Human gastric mucin. Identification of a unique species by expression cloningN W Toribara, A M Roberton, S B Ho, et al.
Pageof 106